Trial Details

Not Recruiting
Basic Information
Clinical ID c3332
Identifier EUCTR2007-006692-37-GB
Trial Title _ The Immunomodulatory Role of Vitamin D in Inflammatory Bowel Disease (IBDVit):_ IBDVit1 - Trial of Adjuvant Vitamin D with Corticosteroids in Active Crohn's Disease;_ IBDVit2 - Trial of Adjuvant Vitamin D with Infliximab in Active Crohn's Disease;_ IBDVit3 - Trial of Adjuvant Vitamin D with standard maintenance therapy in preventing relapse of Inflammatory Bowel Disease._ - IBDVit
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions _ IBDVit1 - Active Crohn's Disease_ IBDVit2 - Active Crohn's Disease_ IBDVit3 - Crohn's Disease in remission / Ulcerative Colitis in remission_ _ MedDRA version: 9.1_ Level: LLT_ Classification code 10011401_ Term: Crohn's disease_ _ MedDRA version: 9.1_ Level: LLT_ Classification code 10045365_ Term: Ulcerative colitis_
Interventions Trade Name: Vigantol Oel Product Name: Vigantol Oel TM Pharmaceutical Form: Oral liquid Pharmaceutical form of the placebo: Oral liquid Route of administration of the placebo: Oral use
Participant Information
Sponsor Imperial College London
City -
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -